A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
Clinical trial NCT02224690 · COMPLETED
Trial details
- NCT number
- NCT02224690
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-28
- Primary completion
- 2016-03-18
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.